SNAP-8: 289 published COA source records
1 study on SNAP-8 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab indexes 289 published SNAP-8 COA source records from third-party laboratories, covering 150 publicly attributable vendor identities. Across 260 records with positive numeric purity, the arithmetic mean is 99.2%. 0 records report zero purity; these remain in the record count and are excluded from the positive-purity mean. 0 positive purity results are below 90%; 1 record reports measured amount more than 10% below the label. The latest recorded test date is 2026-09-19. TitrateLab did not perform these laboratory tests. Source records are not unique batches, and vendor identity does not establish manufacturing role, product safety or overall quality.
SNAP-8 average prices
As of 2026-09-24, vendor-blind retail asking-price averages for the US delivery market, calculated from the same in-stock exact-strength cells as the Peptide Price Index. Shipping is excluded.
| Strength | Average / vial | Observed range / vial | Average / mg | Coverage |
|---|---|---|---|---|
| 10 mg | $6.83 | $5.50–$8.50 | $0.68 | 3 sources · 3 offers |
Asking prices are not manufacturing cost and do not establish product equivalence, quality, safety, or legality. The refresh date is the catalog build date; individual source observation dates are not available in this snapshot. View full price methodology →
SNAP-8: published third-party laboratory evidence
All published source records, including absent and zero purity. Matching uses a case-insensitive exact peptide token. No deduplication in the headline; vendor rankings deduplicate eligible certificates separately. The COA archive can use normalized compound names and a different measurement or duplicate policy; totals from these populations need not match.
Latest recorded test: 2026-09-19. Aggregate calculated: 2026-09-24T18:22:45.056710+00:00. Calculation time is not a laboratory observation date.
Within that total, 53 source records have unresolved vendor identity. They remain in corpus-level lab evidence and are excluded from named-vendor rankings.
Top 3 vendor evidence profiles for SNAP-8
Eligible vendors have at least 2 deduplicated certificates and 2 classifiable identity observations. Rank uses the 95% lower confidence bound on clean identity results; mean positive purity and certificate count break ties. Missing measurements are not passes. Exact-zero/not-detected and explicit wrong-compound markers count once per adverse certificate. This describes submitted-sample evidence, not every product or shipment, and is not an endorsement.
| Rank | Vendor | Deduplicated certificates | Avg positive purity | Identity adverse results | |
|---|---|---|---|---|---|
| #1 | 13 | 98.57% | 0 of 13 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #2 | 7 | 97.34% | 0 of 7 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #3 | 6 | 99.74% | 0 of 6 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → |
Vendor identities are included with Pro. Record counts and lab measurements remain visible.
Recent source records: #109453 (99.83%) · #109460 (99.91%) · #109377 (99.55%) · #107766 (99.47%) · #106514 (99.7%) · #105731 (99.56%)
SNAP-8 studies and clinical research
-
Snap-8 PubChem Profile Details Molecular Structure, Formula, and Weight
Snap-8, a synthetic octapeptide, is characterized by its molecular formula C42H72N16O15S and molecular weight of 1073.2 g/mol in its PubChem profile.
Research tools
Free, no account — handy when you're working with SNAP-8.
